- Home
- RGNX vs OMDA Comparison
RGNX vs OMDA Comparison
Compare RGNX & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | OMDA |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 761.9M | 897.6M |
| IPO Year | 2015 | 2025 |
Fundamental Metrics
Financial Performance| Metric | RGNX | OMDA |
|---|---|---|
| Price | $14.94 | $15.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 10 |
| Target Price | ★ $30.78 | $24.80 |
| AVG Volume (30 Days) | 706.5K | ★ 956.9K |
| Earning Date | 03-12-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $161,318,000.00 | ★ $232,342,000.00 |
| Revenue This Year | $133.58 | $52.16 |
| Revenue Next Year | $45.08 | $22.55 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 91.30 | 89.23 |
| 52 Week Low | $5.04 | $14.14 |
| 52 Week High | $15.84 | $28.40 |
Technical Indicators
Market Signals| Indicator | RGNX | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | N/A |
| Support Level | $13.40 | N/A |
| Resistance Level | $15.31 | N/A |
| Average True Range (ATR) | 0.96 | 0.00 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 70.71 | 0.00 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About OMDA Omada Health Inc.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.